The biological bases of endocrine alterations in ageing men are now we
ll identified: progressive impairment of testicular function, decline
in growth hormone (GH) secretion with decreased insulin-like growth fa
ctor-I (IGF-T) levels, and reduced adrenal androgen secretion. Insulin
resistance and glucose intolerance also accompany male ageing. The me
chanisms of these age-related changes are still unknown. There are pre
liminary results on the effects of hormonal replacement therapy in old
er males with mild hypogonadism or decreased IGF-I levels. Controlled
placebo studies will in the future define the risks and benefits of lo
ng-term administration of androgens, GH or GH-releasing hormone in the
se patients. In view of the severe potential side effects, the general
ized use of hormonal substitution in elderly men cannot, for the momen
t, be recommended.